Why Is Quest Diagnostics Stock Falling Today? DGX -5.27% (Sep 22)

Analysis Date: September 22, 2026. Quest Diagnostics (DGX) shares sank -5.27% today in a sharp sell-off. Here's the reason for the Quest Diagnostics share-price drop today — why is DGX stock down today?

Ticker
DGX
Company
Quest Diagnostics
Direction
Down
% Change
-5.27%
Date
September 22, 2026

Quest Diagnostics (NYSE: DGX) shares declined 5.27% on September 22, 2026, in a notable single-session move for one of the largest clinical laboratory networks in the United States.

  • The drop occurred amid broader healthcare sector headwinds, with no single company-specific operational catalyst publicly confirmed for the session.
  • Quest Diagnostics recently published a study finding high co-exposure rates among patients with tick-borne diseases, demonstrating the company's broad diagnostic testing capabilities.
  • Moves of this magnitude in large-cap diagnostics names often reflect investor concerns around reimbursement rates, healthcare spending trends, or macro-level sector rotation.
  • Analysts and investors are expected to seek further clarity on the company's near-term financial outlook in upcoming earnings communications.

This content is for informational and educational purposes only. It is not investment advice.

DGX intraday price — September 22, 2026Quest Diagnostics (DGX) intraday price on September 22, 2026: opened at $229.31, ranged $229.31 to $236.63, last $232.22 at 11:05 AM ET — down 5.19% versus the previous close of $244.93. IEX data, 15-minute delayed.$235.67$233.85$232.02Prev close $244.93$232.22-5.19%9:30 AM ET11:05 AM ET
DGX trading snapshot — September 22, 2026. IEX data, 15-minute delayed.
Previous close$244.93
Open$229.31
Intraday high$236.63
Intraday low$229.31
Last price at trigger$232.02
Change vs previous close-5.27%
  1. Quest Diagnostics published a study finding high co-exposure rates among patients with tick-borne diseases, highlighting the company's broad diagnostic testing capabilities.Zacks Investment Research
Why is Quest Diagnostics stock down today?

Quest Diagnostics (DGX) shares sank -5.27% on September 22, 2026. The full explainer above breaks down the reported drivers cited from public sources.

Why did DGX plummet today?

According to the cited sources, the move on September 22, 2026 was driven by the catalyst summarized in the explainer. See the Sources list below for primary references.

What caused Quest Diagnostics stock to crash today?

Quest Diagnostics (NYSE: DGX) shares declined 5.27% on September 22, 2026, in a notable single-session move for one of the largest clinical laboratory networks in the United States.

DGX stock drop reason today?

Quest Diagnostics shares closed down -5.27% on September 22, 2026 — a drop of 5.27% from the prior close.

Is this investment advice?

No. Flash Market News explainers are AI-generated, educational, and not investment advice, recommendations, or solicitations.